FDA Inspection
Emory Reproductive CenterEmory Reproductive Center – FDA Inspection, Nov 13, 2019
Record Details
This FDA Inspection record concerns Emory Reproductive Center, with an inspection on November 13, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Emory Reproductive Center
- Inspection Date
- November 13, 2019
- Product Type
- Biologics
View Company Profile
ID · 5f50da74-459d-42f8-8c57-4dd0bf05fcf3
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1114229
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Emory Reproductive Center
7| Date | Classification | Office | Project area |
|---|---|---|---|
| April 28, 2026 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 15, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| December 13, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 16, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 30, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Emory Reproductive Center
- FDA Inspection 1316804 - 2026-04-28
- FDA Inspection 1193371 - 2022-11-15
- FDA Inspection 1038776 - 2017-12-13
- FDA Inspection 962354 - 2016-03-16
- FDA Inspection 885694 - 2014-06-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.